HAP Trading’s iShares Biotechnology ETF IBB Stock Holding History

HAP Trading’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,063	Closed	-$1.32M	–	1424
2022 Q4	$1.32M	Buy	+10,063	New	+$1.3M	0.13%	159
2022 Q1	–	Sell	-11,105	Closed	-$1.45M	–	2486
2021 Q4	$1.7M	Buy	+11,105	New	+$1.72M	0.05%	340
2021 Q3	–	Sell	-14,380	Closed	-$2.42M	–	2562
2021 Q2	$2.35M	Buy	14,380 +4,373	+44%	+$674K	0.07%	250
2021 Q1	$1.51M	Sell	10,007 -12,822	-56%	-$2.04M	0.08%	234
2020 Q4	$3.46M	Buy	22,829 +3,371	+17%	+$482K	0.1%	175
2020 Q3	$2.63M	Buy	+19,458	New	+$2.64M	0.13%	126
2019 Q1	–	Sell	-13,593	Closed	-$1.49M	–	1222
2018 Q4	$1.31M	Buy	+13,593	New	+$1.44M	0.08%	196
2015 Q1	–	Sell	-147,276	Closed	-$16.2M	–	1067
2014 Q4	$14.9M	Buy	+147,276	New	+$14.3M	0.55%	42
2014 Q1	–	Sell	-74,631	Closed	-$6.22M	–	1192
2013 Q4	$5.65M	Buy	74,631 +17,301	+30%	+$1.23M	0.18%	121
2013 Q3	$4M	Buy	+57,330	New	+$3.76M	0.13%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HAP Trading's IBB Position: Q1 2023 in Review

HAP Trading sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 10,063 shares — an estimated $1.32M sold.

HAP Trading first reported a position in IBB in Q3 2013 and held it in 10 quarters. The position peaked at $14.9M in Q4 2014. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

HAP Trading reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
HAP Trading sold 10,063 iShares Biotechnology ETF shares in Q1 2023, an estimated $1.32M.
HAP Trading first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 10 quarters.
HAP Trading's iShares Biotechnology ETF position peaked at $14.9M in Q4 2014.
867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.